Can Neil Woodford’s reputation survive three years of under-performance?

Neil Woodford’s annus horribilis has emboldened his detractors, but Harvey Jones is standing by his man for now.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You have to feel sorry for the super-successful, super-wealthy star fund manager Neil Woodford, who is suddenly in the headlines for the wrong reasons. After three decades of stonking outperformance, the knives are flashing. One annus horribilis is all it takes. Well, arguably, three years. So is the great man finished? Could be. It can happen to the best.


August’s headlines made ugly reading. “Star investor Woodford hit by fortnight from hell.” “Yet another Woodford debacle.” “What’s going wrong with Woodford?” And those are the polite ones. One or two I would blush to repeat here.

5 Stocks For Trying To Build Wealth After 50

One notable billionaire made 99% of his current wealth after his 50th birthday. And here at The Motley Fool, we believe it is NEVER too late to start trying to build your fortune in the stock market. Our expert Motley Fool analyst team have shortlisted 5 companies that they believe could be a great fit for investors aged 50+ trying to build long-term, diversified portfolios.

Click here to claim your free copy now!

Things came to a head with the Provident Financial meltdown. Woodford owns a 19% stake in the doorstep lender and lost £326m when its shares crashed almost 70% in a day. Bad news comes in threes, the superstitious say, and Woodford has suffered a triple blow this year. In July, pharmaceuticals giant AstraZeneca, the biggest holding in CF Woodford Equity Income, plunged 15%, its largest ever fall. In April, outsize holding Allied Minds also suffered its biggest ever drop (Woodford holds more than a quarter of its stock).

Earnestly speaking

As Oscar Wilde might have put it: To suffer one high-profile stock meltdown, Mr Woodford, may be regarded as a misfortune, to have two looks like carelessness. But three? Actually, I count four, including biotech stock Sphere Medical Holdings, which features in his dismal Patient Capital Trust. Wilde said nothing about four indignities, which turns into five if you include the AA, whose shares tanked after chief executive Bob Mackenzie’s alleged bar punch-up madenews.

I have made good money from his triumphant Invesco Perpetual Income fund, so I owe a degree of loyalty. He has shown similar loyalty to his stock picks, routinely rushing to their defence, claiming for example that Provident Financial is now seriously undervalued.

Sinking ship

So let’s visit to examine the performance of his flagship CF Woodford Equity Income, launched in June 2014. The £9.25bn fund is down -0.3% over the last year while its benchmark UK equity income sector is up a buoyant 10.5%. Embarrassingly, it is the sector’s worst performer over three, six and 12 months and is only keeping its head above water thanks to a stonking first year, when it grew 16% against 2.8% for its sector.

Over three years Woodford has posted a second quartile showing of 25.2% but does not trouble the top 10. First-placed MI Chelverton UK Equity Income returned 41.6%, while even 10th-placed Neptune Income beat Woodford with 31.1%.

Patient diagnosis

Woodford Patient Capital Trust has done worse, rising 3.8% in the last year against 16.3% on the All Companies index, after falling 18.5% the year before, against a 1.1% rise. I think there is a serious danger that Woodford is out of his depth here in his pursuit of smaller quoted and unquoted companies.

I will continue to hold CF Woodford Equity Income. Woodford has suffered periods of underperformance before and emerged with his reputation enhanced. However, that was often through making heroic contrarian calls, such as shunning booming tech and banking stocks. His recent troubles are down to poor stock picking, which is less heroic.

Woodford does invest in a lot of companies, and some will go wrong. But maybe running his own asset management company was a step too far? I detect signs of arrogance. Despite all this, I still reckon his star will shine again.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Harvey Jones hold units in Invesco Perpetual Income and CF Woodford Equity Income. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A beach at sunset where there is an inscription on the sand "Breathe Deeeply".
Investing Articles

Stock market crash: here’s why falling prices is good news

Over in the US, a stock market crash is battering high-priced stocks. But I see falling shares as an opportunity…

Read more »

Hand flipping wooden cubes for change wording" Panic " to " Calm".
Investing Articles

These 5 FTSE 100 shares crashed in 2022. I’d buy 1 today

Although the FTSE 100 index is flat in 2022, some Footsie shares have crashed hard this year. But I see…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

How investors can boost their passive income when the FTSE is falling

Stock markets are plagued with fears right now. Here's why I firmly believe those fears improve our passive income prospects.

Read more »

Image of person checking their shares portfolio on mobile phone and computer
Investing Articles

2 cheap UK shares to buy right now!

Recent market volatility means many top stocks now trade at rock-bottom prices. Here are two cheap UK shares I'm thinking…

Read more »

Rolls-Royce's business aviation engine, the Pearl 700
Investing Articles

The Rolls-Royce share price is just pennies. Am I missing something?

As the Rolls-Royce share price lingers in penny stock territory, our writer revisits the investment case that has attracted him…

Read more »

Compass pointing towards 'best price'
Investing Articles

How to put a valuation on the Woodbois share price

The Woodbois share price has fallen from its recent spike, so should I buy now? And how can I work…

Read more »

Inflation in newspapers
Investing Articles

I’d fight inflation with these 2 FTSE 100 dividend shares

With inflation hitting a 9%, I'm boosting my passive income and turning to these two FTSE 100 dividend stocks.

Read more »

New Ways of Investing - Hands Only Using Smart Phone
Investing Articles

2 cheap Footsie stocks to buy for BIG dividends!

The recent stock market sell-off leaves plenty of top stocks looking too cheap to miss. Here are two great Footsie…

Read more »